CLEC-2 is required for development and maintenance of lymph nodes

被引:56
|
作者
Benezech, Cecile [1 ]
Nayar, Saba [1 ]
Finney, Brenda A. [2 ]
Withers, David R. [1 ]
Lowe, Kate [2 ]
Desanti, Guillaume E. [1 ]
Marriott, Clare L. [1 ]
Watson, Steve P. [2 ]
Caamano, Jorge H. [1 ]
Buckley, Christopher D. [1 ]
Barone, Francesca [1 ]
机构
[1] Univ Birmingham, Sch Immun & Infect, Birmingham, W Midlands, England
[2] Univ Birmingham, Coll Med & Dent Sci, Ctr Cardiovasc Sci, Birmingham, W Midlands, England
基金
英国惠康基金; 英国生物技术与生命科学研究理事会;
关键词
HIGH ENDOTHELIAL VENULES; FORMATION IN-VITRO; CELL-INTERACTIONS; RECEPTOR CLEC-2; PODOPLANIN; PLATELETS; VESSELS; VIVO; ORGANIZATION; VASCULATURE;
D O I
10.1182/blood-2013-03-489286
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The importance of CLEC-2, a natural ligand/receptor for Gp38/Podoplanin, in the formation of the lymphatic vasculature has recently been demonstrated. As the development and maintenance of lymph nodes (LNs) is dependent on the formation of the lymphatic vasculature and the differentiation of Gp38/Podoplanin(+) stromal cells, we investigated the role of CLEC-2 in lymphoneogenesis and LN homeostasis. Using constitutive Clec1b(-/-) mice, we showed that while CLEC-2 was not necessary for initiation of the LN anlage, it was required at late stages of development. Constitutive deletion of CLEC-2 induced a profound defect in lymphatic endothelial cell proliferation, resulting in lack of LNs at birth. In contrast, conditional deletion of CLEC-2 in the megakaryocyte/platelet lineage in Clec1b(fl/fl) PF4-Cre mice led to the development of blood-filled LNs and fibrosis, in absence of a proliferative defect of the lymphatic endothelial compartment. This phenotype was also observed in chimeric mice reconstituted with Clec1b(fl/fl) PF4-Cre bone marrow, indicating that CLEC-2 expression in platelets was required for LN integrity. We demonstrated that LNs of Clec1b(fl/fl) PF4-Cre mice are able to sustain primary immune responses but show a defect in immune cell recirculation after repeated immunizations, thus suggesting CLEC-2 as target in chronic immune response.
引用
收藏
页码:3200 / 3207
页数:8
相关论文
共 50 条
  • [41] CLEC-2 expression is maintained on activated platelets and on platelet microparticles
    Gitz, Eelo
    Pollitt, Alice Y.
    Gitz-Francois, Jerney J.
    Alshehri, Osama
    Mori, Jun
    Montague, Samantha
    Nash, Gerard B.
    Douglas, Michael R.
    Gardiner, Elizabeth E.
    Andrews, Robert K.
    Buckley, Christopher D.
    Harrison, Paul
    Watson, Steve P.
    BLOOD, 2014, 124 (14) : 2262 - 2270
  • [42] PODOPLANIN AND ITS LIGAND CLEC-2 RESTRAIN SYNOVIAL INFLAMMATION
    Desanti, G. E.
    Naylor, A. J.
    Nunez, L. Navarro
    Saghir, A. N.
    Hardie, D. L.
    Watson, S. P.
    Buckley, C. D.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : A7 - A7
  • [43] Platelets play an essential role in murine lung development through Clec-2/podoplanin interaction
    Tsukiji, Nagaharu
    Inoue, Osamu
    Morimoto, Mitsuru
    Tatsumi, Norifumi
    Nagatomo, Hiroaki
    Ueta, Koji
    Shirai, Toshiaki
    Sasaki, Tomoyuki
    Otake, Shimon
    Tamura, Shogo
    Tachibana, Toshiaki
    Okabe, Masataka
    Hirashima, Masanori
    Ozaki, Yukio
    Suzuki-Inoue, Katsue
    BLOOD, 2018, 132 (11) : 1167 - 1179
  • [44] Clec-2 Regulates Type 2 And Type 17 Lung Inflammation
    Burkett, P.
    Wallrapp, A.
    Kuchroo, V. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [45] Katacine Is a New Ligand of CLEC-2 that Acts as a Platelet Agonist
    Moran, Luis A.
    Di, Ying
    Sowa, Marcin A.
    Hermida-Nogueira, Lidia
    Barrachina, Maria N.
    Martin, Eleyna
    Clark, Joanne C.
    Mize, Todd H.
    Eble, Johannes A.
    Moreira, David
    Pollitt, Alice Y.
    Loza, Maria, I
    Dominguez, Eduardo
    Watson, Steve P.
    Garcia, Angel
    THROMBOSIS AND HAEMOSTASIS, 2022, 122 (08) : 1361 - 1368
  • [46] Crystallization and X-ray diffraction analysis of human CLEC-2
    Watson, AA
    O'Callaghan, CA
    ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2005, 61 : 1094 - 1096
  • [47] CLEC-2 in megakaryocytes is critical for maintenance of hematopoietic stem cells in the bone marrow (vol 212, pg 2133, 2015)
    Nakamura-Ishizu, Ayako
    Takubo, Keiyo
    Kobayashi, Hiroshi
    Suzuki-Inoue, Katsue
    Suda, Toshio
    JOURNAL OF EXPERIMENTAL MEDICINE, 2015, 212 (13): : 2323 - 2323
  • [48] Elucidating the CLEC-2 signaling cascade using a global proteomics approach
    Garcia, A.
    Parguina, A. F.
    Rosa, I
    Eble, J. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 784 - 784
  • [49] Novel platelet activation receptor CLEC-2: from discovery to prospects
    Suzuki-Inoue, K.
    Inoue, O.
    Ozaki, Y.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 500 - 501
  • [50] CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis
    May, Frauke
    Hagedorn, Ina
    Pleines, Irina
    Bender, Markus
    Voegtle, Timo
    Eble, Johannes
    Elvers, Margitta
    Nieswandt, Bernhard
    BLOOD, 2009, 114 (16) : 3464 - 3472